Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Spinal Fusion Devices Market by Type (Thoracolumbar Devices, Cervical Fixation Devices, Interbody Fusion Devices), by Surgery (Minimally Invasive Spine Surgery, Open Spine Surgery), by End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

A01626

Pages: 230

Charts: 54

Tables: 120

Spinal Fusion Devices Market Statistics, 2030

The global spinal fusion devices market size was valued at $7,030.1 million in 2020, and is projected to reach $11,434.1 million by 2030, growing at CAGR of 4.6% from 2021 to 2030. Growth of the market is driven by increase in geriatric population and rise in incidences of spinal disorders. Spinal fusion devices are used for treatment of spinal deformities such as degenerative disc disease and spondylolisthesis. Growth of the market is driven by increase in geriatric population and rise in incidences of spinal disorders. In addition, expansion in indications for which spinal fusion surgery is performed boosts the market growth. For instance, originally spinal fusion was performed solely for scoliosis and spinal tuberculosis, however, there are 14 conditions for which spinal fusion procedure is currently indicated. In addition, in 2020 there were 1,53,288 anterior cervical discectomy and fusions were performed in the U.S and the volume is expected to increase by 13.3% by 2040.

Spinal disorders such as spinal stenosis is the most common problem in men and women over 50 years. Ageing population is at a high risk for spinal impairments, including those with comorbidities and/or compromised immunity. Spine level treatment options are continuously evolving with introduction of new age spine fusion and devices. Further, use of these implants and devices is being one of the effective and recommended options for treatment of spine misalignments or degenerative changes. Major factor that contributes toward growth of the spinal fusion devices market include shift toward minimally invasive spins procedures, increase in prevalence of spinal disorders, and advancements in spine surgery. Spinal fusion devices market forecast from 2020 to 2030.

Asia-Pacific possesses high market potential for spinal fusion devices, owing to rise in incidences of spinal disorders and increase in healthcare expenditure. Furthermore, rapidly aging population, low cost of spinal procedures in countries such as India as compared developed countries such as the U.S. have further increased demand for spinal implants. Spinal surgery is performed at over 2,000 hospitals in India, with complex and sophisticated surgeries such as microscopic spine surgery being performed in at least 500 multi-faculty spinal surgery hospitals and super specialty hospitals. Therefore, the aforementioned factors are projected to propel demand for spinal fusion devices.

The coronavirus disease (COVID-19) has spread across the globe. Further, owing to increase in number of corona virus patients, governments have imposed several rules and lockdown across the globe, which has resulted into closure of manufacturing and production operations of companies operating in the spinal fusion devices market. In addition, hospitals have also independently announced reduction, postponement, or cancelation of elective surgeries, including many orthopedic and spine cases as practitioners and surgeons are engaged in treating corona patients. This discontinuity in proceedings of business operations and other related procedures directly influences revenue drift of the market. Therefore, the aforementioned factors are expected to hamper the spinal fusion devices market growth.

However, unfavorable reimbursement scenario and stringent regulatory approval procedure of these devices are expected to limit the market growth. On the contrary, emerging markets are expected to drive demand for spinal implants and devices. In addition, advancements in augmented and virtual reality, endoscopic surgery, and 3D printed implants for minimally invasive surgery is also expected to fuel the market growth.

Global Spinal Fusion Devices Market Segmentation

The global spinal fusion devices market is segmented into product, surgery, and end user.

By Product Type

On the basis of product, the market is divided into thoracolumbar devices, cervical fusion devices, and interbody fusion devices. Thoracolumbar devices having the largest share for spinal fusion devices industry.

[TYPEGRAPH]

By Surgery

On the basis of surgery, it is classified into open spine surgery and minimally invasive spine surgery. By end user it is divided into hospitals, specialty clinics, and others. Hospitals segment having the largest spinal fusion devices market share.

[SURGERYGRAPH]

By Region

On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is expected to hold the highest market share during the forecast period.

[REGIONGRAPH]

Competitive Analysis

Major players such as Alphatec Holdings, Inc., B.Barun Melsungen AG, and Stryker Corporation. are adopting acquisition strategy to improve their product portfolio to maintain competition in the market. For instance, in December 2020, Alphatec entered into an agreement to acquire EOS imaging, S.A., which is globally recognized for biplanar full body imaging and 3D modeling capabilities. This acquisition aims to improve the inventory efficiency and product portfolio. Such instances are expected to provide lucrative opportunities for major players for growth of the market. Spinal fusion devices market size are reported from 2020 to 2030.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the spinal fusion devices market analysis from 2020 to 2030 to identify the prevailing spinal fusion devices industry opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Spinal fusion devices market opportunity are reported from 2020 to 2030.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the spinal fusion devices market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global spinal fusion devices market trends, key players, market segments, spinal fusion devices market size, application areas, and market growth strategies.

Key Market Segments

  • By Type
    • Thoracolumbar Devices
    • Cervical Fixation Devices
    • Interbody Fusion Devices
  • By Surgery
    • Minimally Invasive Spine Surgery
    • Open Spine Surgery
  • By End User
    • Hospitals
    • Specialty Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • Italy
      • France
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest Of Asia Pacific
    • LAMEA
      • Rest of Latin America
      • Middle East
      • Africa


Key Market Players

  • Alphatec Holdings Inc
  • Nuvasive Inc
  • Globus Medical Inc
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Orthofix International N.V.
  • Stryker Corporation.
  • Johnson & Johnson
  • Medtronic Plc
  • Exactech Inc
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Low bargaining power of suppliers

      • 3.3.2. Low threat of new entrants

      • 3.3.3. Low threat of substitutes

      • 3.3.4. Low intensity of rivalry

      • 3.3.5. Low bargaining power of buyers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in geriatric population
        • 3.4.1.2. rise in incidences of spinal disorders

      • 3.4.2. Restraints

        • 3.4.2.1. unfavorable reimbursement scenario

      • 3.4.3. Opportunities

        • 3.4.3.1. increase in healthcare expenditure

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: SPINAL FUSION DEVICES MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Thoracolumbar Devices

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Cervical Fixation Devices

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

    • 4.4. Interbody Fusion Devices

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis by country

  • CHAPTER 5: SPINAL FUSION DEVICES MARKET, BY SURGERY

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Minimally Invasive Spine Surgery

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Open Spine Surgery

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

  • CHAPTER 6: SPINAL FUSION DEVICES MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Specialty Clinics

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Others

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: SPINAL FUSION DEVICES MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Type

      • 7.2.3. Market size and forecast, by Surgery

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Type
          • 7.2.5.1.3. Market size and forecast, by Surgery
          • 7.2.5.1.4. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Type
          • 7.2.5.2.3. Market size and forecast, by Surgery
          • 7.2.5.2.4. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Type
          • 7.2.5.3.3. Market size and forecast, by Surgery
          • 7.2.5.3.4. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Type

      • 7.3.3. Market size and forecast, by Surgery

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Type
          • 7.3.5.1.3. Market size and forecast, by Surgery
          • 7.3.5.1.4. Market size and forecast, by End User
        • 7.3.5.2. Italy
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Type
          • 7.3.5.2.3. Market size and forecast, by Surgery
          • 7.3.5.2.4. Market size and forecast, by End User
        • 7.3.5.3. France
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Type
          • 7.3.5.3.3. Market size and forecast, by Surgery
          • 7.3.5.3.4. Market size and forecast, by End User
        • 7.3.5.4. Spain
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Type
          • 7.3.5.4.3. Market size and forecast, by Surgery
          • 7.3.5.4.4. Market size and forecast, by End User
        • 7.3.5.5. Rest of Europe
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Type
          • 7.3.5.5.3. Market size and forecast, by Surgery
          • 7.3.5.5.4. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Type

      • 7.4.3. Market size and forecast, by Surgery

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. China
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Type
          • 7.4.5.1.3. Market size and forecast, by Surgery
          • 7.4.5.1.4. Market size and forecast, by End User
        • 7.4.5.2. Japan
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Type
          • 7.4.5.2.3. Market size and forecast, by Surgery
          • 7.4.5.2.4. Market size and forecast, by End User
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Type
          • 7.4.5.3.3. Market size and forecast, by Surgery
          • 7.4.5.3.4. Market size and forecast, by End User
        • 7.4.5.4. South Korea
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Type
          • 7.4.5.4.3. Market size and forecast, by Surgery
          • 7.4.5.4.4. Market size and forecast, by End User
        • 7.4.5.5. Rest Of Asia Pacific
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Type
          • 7.4.5.5.3. Market size and forecast, by Surgery
          • 7.4.5.5.4. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Type

      • 7.5.3. Market size and forecast, by Surgery

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Rest of Latin America
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Type
          • 7.5.5.1.3. Market size and forecast, by Surgery
          • 7.5.5.1.4. Market size and forecast, by End User
        • 7.5.5.2. Middle East
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Type
          • 7.5.5.2.3. Market size and forecast, by Surgery
          • 7.5.5.2.4. Market size and forecast, by End User
        • 7.5.5.3. Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Type
          • 7.5.5.3.3. Market size and forecast, by Surgery
          • 7.5.5.3.4. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2020

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Alphatec Holdings Inc

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

      • 9.1.7. Key strategic moves and developments

    • 9.2. B. Braun Melsungen AG

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

    • 9.3. Exactech Inc

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

    • 9.4. Globus Medical Inc

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Johnson & Johnson

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

      • 9.5.7. Key strategic moves and developments

    • 9.6. Medtronic Plc

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

      • 9.6.7. Key strategic moves and developments

    • 9.7. Nuvasive Inc

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

      • 9.7.7. Key strategic moves and developments

    • 9.8. Orthofix International N.V.

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

    • 9.9. Stryker Corporation.

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Business performance

    • 9.10. Zimmer Biomet Holdings, Inc.

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

      • 9.10.6. Business performance

  • LIST OF TABLES

  • TABLE 01. GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 02. SPINAL FUSION DEVICES MARKET FOR THORACOLUMBAR DEVICES, BY REGION, 2020-2030 ($MILLION)
    TABLE 03. SPINAL FUSION DEVICES MARKET FOR CERVICAL FIXATION DEVICES, BY REGION, 2020-2030 ($MILLION)
    TABLE 04. SPINAL FUSION DEVICES MARKET FOR INTERBODY FUSION DEVICES, BY REGION, 2020-2030 ($MILLION)
    TABLE 05. GLOBAL SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 06. SPINAL FUSION DEVICES MARKET FOR MINIMALLY INVASIVE SPINE SURGERY, BY REGION, 2020-2030 ($MILLION)
    TABLE 07. SPINAL FUSION DEVICES MARKET FOR OPEN SPINE SURGERY, BY REGION, 2020-2030 ($MILLION)
    TABLE 08. GLOBAL SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 09. SPINAL FUSION DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
    TABLE 10. SPINAL FUSION DEVICES MARKET FOR SPECIALTY CLINICS, BY REGION, 2020-2030 ($MILLION)
    TABLE 11. SPINAL FUSION DEVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
    TABLE 12. SPINAL FUSION DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
    TABLE 13. NORTH AMERICA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 14. NORTH AMERICA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 15. NORTH AMERICA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 16. NORTH AMERICA SPINAL FUSION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
    TABLE 17. U.S. SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 18. U.S. SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 19. U.S. SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 20. CANADA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 21. CANADA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 22. CANADA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 23. MEXICO SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 24. MEXICO SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 25. MEXICO SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 26. EUROPE SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 27. EUROPE SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 28. EUROPE SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 29. EUROPE SPINAL FUSION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
    TABLE 30. GERMANY SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 31. GERMANY SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 32. GERMANY SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 33. ITALY SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 34. ITALY SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 35. ITALY SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 36. FRANCE SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 37. FRANCE SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 38. FRANCE SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 39. SPAIN SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 40. SPAIN SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 41. SPAIN SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 42. REST OF EUROPE SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 43. REST OF EUROPE SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 44. REST OF EUROPE SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 45. ASIA-PACIFIC SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 46. ASIA-PACIFIC SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 47. ASIA-PACIFIC SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 48. ASIA-PACIFIC SPINAL FUSION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
    TABLE 49. CHINA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 50. CHINA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 51. CHINA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 52. JAPAN SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 53. JAPAN SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 54. JAPAN SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 55. INDIA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 56. INDIA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 57. INDIA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 58. SOUTH KOREA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 59. SOUTH KOREA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 60. SOUTH KOREA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 61. REST OF ASIA PACIFIC SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 62. REST OF ASIA PACIFIC SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 63. REST OF ASIA PACIFIC SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 64. LAMEA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 65. LAMEA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 66. LAMEA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 67. LAMEA SPINAL FUSION DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
    TABLE 68. REST OF LATIN AMERICA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 69. REST OF LATIN AMERICA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 70. REST OF LATIN AMERICA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 71. MIDDLE EAST SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 72. MIDDLE EAST SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 73. MIDDLE EAST SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 74. AFRICA SPINAL FUSION DEVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
    TABLE 75. AFRICA SPINAL FUSION DEVICES MARKET, BY SURGERY, 2020-2030 ($MILLION)
    TABLE 76. AFRICA SPINAL FUSION DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
    TABLE 77. ALPHATEC HOLDINGS INC: KEY EXECUTIVES
    TABLE 78. ALPHATEC HOLDINGS INC: COMPANY SNAPSHOT
    TABLE 79. ALPHATEC HOLDINGS INC: PRODUCT SEGMENTS
    TABLE 80. ALPHATEC HOLDINGS INC: PRODUCT PORTFOLIO
    TABLE 81. ALPHATEC HOLDINGS INC: KEY STRATERGIES
    TABLE 82. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
    TABLE 83. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
    TABLE 84. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
    TABLE 85. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
    TABLE 86. EXACTECH INC: KEY EXECUTIVES
    TABLE 87. EXACTECH INC: COMPANY SNAPSHOT
    TABLE 88. EXACTECH INC: PRODUCT SEGMENTS
    TABLE 89. EXACTECH INC: PRODUCT PORTFOLIO
    TABLE 90. GLOBUS MEDICAL INC: KEY EXECUTIVES
    TABLE 91. GLOBUS MEDICAL INC: COMPANY SNAPSHOT
    TABLE 92. GLOBUS MEDICAL INC: PRODUCT SEGMENTS
    TABLE 93. GLOBUS MEDICAL INC: PRODUCT PORTFOLIO
    TABLE 94. JOHNSON & JOHNSON: KEY EXECUTIVES
    TABLE 95. JOHNSON & JOHNSON: COMPANY SNAPSHOT
    TABLE 96. JOHNSON & JOHNSON: PRODUCT SEGMENTS
    TABLE 97. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
    TABLE 98. JOHNSON & JOHNSON: KEY STRATERGIES
    TABLE 99. MEDTRONIC PLC: KEY EXECUTIVES
    TABLE 100. MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 101. MEDTRONIC PLC: PRODUCT SEGMENTS
    TABLE 102. MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 103. MEDTRONIC PLC: KEY STRATERGIES
    TABLE 104. NUVASIVE INC: KEY EXECUTIVES
    TABLE 105. NUVASIVE INC: COMPANY SNAPSHOT
    TABLE 106. NUVASIVE INC: PRODUCT SEGMENTS
    TABLE 107. NUVASIVE INC: PRODUCT PORTFOLIO
    TABLE 108. NUVASIVE INC: KEY STRATERGIES
    TABLE 109. ORTHOFIX INTERNATIONAL N.V.: KEY EXECUTIVES
    TABLE 110. ORTHOFIX INTERNATIONAL N.V.: COMPANY SNAPSHOT
    TABLE 111. ORTHOFIX INTERNATIONAL N.V.: PRODUCT SEGMENTS
    TABLE 112. ORTHOFIX INTERNATIONAL N.V.: PRODUCT PORTFOLIO
    TABLE 113. STRYKER CORPORATION.: KEY EXECUTIVES
    TABLE 114. STRYKER CORPORATION.: COMPANY SNAPSHOT
    TABLE 115. STRYKER CORPORATION.: PRODUCT SEGMENTS
    TABLE 116. STRYKER CORPORATION.: PRODUCT PORTFOLIO
    TABLE 117. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
    TABLE 118. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
    TABLE 119. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT SEGMENTS
    TABLE 120. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 1.SPINAL FUSION DEVICES MARKET SEGMENTATION
    FIGURE 2.SPINAL FUSION DEVICES MARKET,2020-2030
    FIGURE 3.SPINAL FUSION DEVICES MARKET,2020-2030
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.SPINAL FUSION DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 11.SPINAL FUSION DEVICES MARKET,BY TYPE,2020(%)
    FIGURE 12.COMPARATIVE SHARE ANALYSIS OF THORACOLUMBAR DEVICES SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CERVICAL FIXATION DEVICES SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTERBODY FUSION DEVICES SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 15.SPINAL FUSION DEVICES MARKET,BY SURGERY,2020(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MINIMALLY INVASIVE SPINE SURGERY SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OPEN SPINE SURGERY SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 18.SPINAL FUSION DEVICES MARKET,BY END USER,2020(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS SPINAL FUSION DEVICES MARKET,2020-2030(%)
    FIGURE 22.SPINAL FUSION DEVICES MARKET BY REGION,2020
    FIGURE 23.U.S. SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 24.CANADA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 25.MEXICO SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 26.GERMANY SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 27.ITALY SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 28.FRANCE SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 29.SPAIN SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 30.REST OF EUROPE SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 31.CHINA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 32.JAPAN SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 33.INDIA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 34.SOUTH KOREA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 35.REST OF ASIA PACIFIC SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 36.REST OF LATIN AMERICA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 37.MIDDLE EAST SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 38.AFRICA SPINAL FUSION DEVICES MARKET,2020-2030($MILLION)
    FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 43.COMPETITIVE DASHBOARD
    FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 45.ZIMMER BIOMET HOLDINGS, INC..: NET SALES ,($MILLION)
    FIGURE 46.ALPHATEC HOLDINGS INC.: NET SALES ,($MILLION)
    FIGURE 47.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
    FIGURE 48.EXACTECH INC.: NET SALES ,($MILLION)
    FIGURE 49.GLOBUS MEDICAL INC.: NET SALES ,($MILLION)
    FIGURE 50.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
    FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 52.NUVASIVE INC.: NET SALES ,($MILLION)
    FIGURE 53.ORTHOFIX INTERNATIONAL N.V..: NET SALES ,($MILLION)
    FIGURE 54.STRYKER CORPORATION.: NET SALES ,($MILLION)

Purchase Full Report of
Spinal Fusion Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue